1. Home
  2. PRTA vs VTEX Comparison

PRTA vs VTEX Comparison

Compare PRTA & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • VTEX
  • Stock Information
  • Founded
  • PRTA 2012
  • VTEX 1999
  • Country
  • PRTA Ireland
  • VTEX United Kingdom
  • Employees
  • PRTA N/A
  • VTEX N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • VTEX Computer Software: Prepackaged Software
  • Sector
  • PRTA Health Care
  • VTEX Technology
  • Exchange
  • PRTA Nasdaq
  • VTEX Nasdaq
  • Market Cap
  • PRTA 1.2B
  • VTEX 1.4B
  • IPO Year
  • PRTA N/A
  • VTEX 2021
  • Fundamental
  • Price
  • PRTA $21.89
  • VTEX $6.69
  • Analyst Decision
  • PRTA Buy
  • VTEX Buy
  • Analyst Count
  • PRTA 7
  • VTEX 6
  • Target Price
  • PRTA $58.83
  • VTEX $10.17
  • AVG Volume (30 Days)
  • PRTA 255.3K
  • VTEX 646.1K
  • Earning Date
  • PRTA 10-31-2024
  • VTEX 11-05-2024
  • Dividend Yield
  • PRTA N/A
  • VTEX N/A
  • EPS Growth
  • PRTA N/A
  • VTEX N/A
  • EPS
  • PRTA N/A
  • VTEX 0.02
  • Revenue
  • PRTA $217,246,000.00
  • VTEX $220,538,000.00
  • Revenue This Year
  • PRTA $59.66
  • VTEX $19.29
  • Revenue Next Year
  • PRTA N/A
  • VTEX $21.45
  • P/E Ratio
  • PRTA N/A
  • VTEX $378.69
  • Revenue Growth
  • PRTA 276.98
  • VTEX 26.45
  • 52 Week Low
  • PRTA $18.69
  • VTEX $4.66
  • 52 Week High
  • PRTA $55.89
  • VTEX $9.59
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.55
  • VTEX 45.60
  • Support Level
  • PRTA $20.15
  • VTEX $6.46
  • Resistance Level
  • PRTA $22.83
  • VTEX $6.93
  • Average True Range (ATR)
  • PRTA 0.82
  • VTEX 0.19
  • MACD
  • PRTA 0.13
  • VTEX -0.04
  • Stochastic Oscillator
  • PRTA 82.66
  • VTEX 31.34

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

Share on Social Networks: